Theratechnologies Inc.
TH.TO
TSX
| 11/30/2024 | 08/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 10.63% | 2.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.63% | 2.65% | |||
| Cost of Revenue | 34.84% | -0.57% | |||
| Gross Profit | 4.57% | 3.49% | |||
| SG&A Expenses | 15.23% | -2.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 46.96% | -12.50% | |||
| Operating Income | -85.21% | 88.96% | |||
| Income Before Tax | -278.89% | 248.14% | |||
| Income Tax Expenses | 35.05% | 540.68% | |||
| Earnings from Continuing Operations | -355.68% | 213.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -355.68% | 213.17% | |||
| EBIT | -85.21% | 88.96% | |||
| EBITDA | -79.96% | 48.15% | |||
| EPS Basic | -355.75% | 213.00% | |||
| Normalized Basic EPS | -125.67% | 247.86% | |||
| EPS Diluted | -366.83% | 200.00% | |||
| Normalized Diluted EPS | -125.67% | 247.86% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.02% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
